Patient


9 results

Neuroscience

EACD 2020: How the use of functional assessments in clinical...

By Andreas Lysandropoulos MD, PhD, Vice President Head Global Medical Affairs Neuroscience at Ipsen An…

Patient

Harnessing the power of real-world data for better, more tar...

By David Loew, CEO Innovation to improve patient outcomes doesn’t always resemble the scenes…

Group

Fulfilling our commitment to employees and mission to patien...

As the COVID-19 pandemic reaches a critical stage in several countries around the world, we…

Patient

Ipsen’s first clinical trial lay summary developed with pati...

Here at Ipsen, we are committed to working with patients, for patients. As part of…

Innovation

#WeWontRest in using digital innovation to transform patient...

[caption id="" align="aligncenter" width="262"] Harout Semerjian, EVP, Chief Commercial Officer, Ipsen[/caption] The European Federation…

Patient

COSMIC-021 trial

As part of Ipsen’s ongoing commitment to improve outcomes for patients with high unmet medical…

Patient

Standby statement on lanreotide generic

Paris (France), April 29, 2019 - Following information regarding the filing of a generic…

Neuroscience

LivingWithNETs.com awarded as Most valuable patient initiati...

LivingWithNETs.com is a dedicated website for patients living with neuroendocrine tumors that was designed with…

Patient

International Childhood Cancer Day, Ipsen mobilizes its team...

The premise is that all children, no matter what their background, have dreams and aspirations.…

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2021